Radionuclide Targeted Therapy, Theranostics, and Precision Medicine in the Era of Hybrid Imaging: An Important Pillar in Cancer Care

Article Sidebar

PDF XML
Published: Mar 6, 2024
DOI: https://doi.org/10.47836/mjmhs18.4.1

Main Article Content

Subapriya Suppiah
Department of Radiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor Darul Ehsan, Malaysia

Abstract

-

Downloads

Download data is not yet available.

Article Details

How to Cite
Subapriya Suppiah. (2024). Radionuclide Targeted Therapy, Theranostics, and Precision Medicine in the Era of Hybrid Imaging: An Important Pillar in Cancer Care. Malaysian Journal of Medicine and Health Sciences, 18(4), 1–3. https://doi.org/10.47836/mjmhs18.4.1
Issue
Vol. 18 No. 4 (2022)
Section
Editorial
Crossref
Scopus
Google Scholar
Europe PMC

References

Global Cancer Observatory (Globocan). Malaysia Fact Sheet on Cancer Cases 2020: World Health Organization; 2020 [Accessed on 1 July 2022]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/458-malaysia-fact-sheets.pdf.

Suppiah S. Nuclear medicine in Malaysia - Strengths and challenges for physicians after more than half a century of experience. Med J Malaysia. 2021;76(4):451-3.

The Lancet. 20 years of precision medicine in oncology. The Lancet. 2021;397(10287):1781.

Panagiotidis E, Alshammari A, Michopoulou S, Skoura E, Naik K, Maragkoudakis E, et al. Comparison of the Impact of 68Ga-DOTATATE

and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors. Journal of Nuclear Medicine. 2017;58(1):91.

Emmett L, Willowson K, Violet J, Shin J, Blanksby A, Lee J. Lutetium (177) PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy. J Med Radiat Sci. 2017;64(1):52-60.